* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Humanitarian Use Device (HUD) Application
Survey
Document related concepts
Transcript
McLeod Health Institutional Review Board Application for Humanitarian use Device (HUD) Complete this form in its entirety. Do not alter, add or delete this form as it will be returned for correction. Information must be typed. Date of Submission: Title of Device or Drug: Manufacturer: Date of Service: Full Board Review Date: Date scheduled for surgery/implant: Principal Physician: Co-Principal Physician: Address: E-mail address: Research Nurse: Telephone: Name and address of all facilities where implant of device will be conducted: Regular usage Other: IRB Concurrence Off label usage: Emergency Compassionate scientific supported usage Informed consent from patient: Yes No Purpose of intended usage(s): Device Procedure Drug Other: Length of Use: Expected number of patients: Expected results of usage: How will the patient be monitored? Is there a conflict of interest: Yes No Documentation to be submitted with this form (checklist) Attach a copy of the proposed informed consent document, if utilized Attach any pertinent documentation: Manufacturer’s product labeling, patient brochure, etc. Attach the FDA HDE approval letter. Attach Physician/Presenter Financial Disclosure Form Attach a copy of the contract agreement with the Sponsor. Attach a current copy of Principal Investigator CV. This study has been reviewed administratively** (VP for area - i.e. Oncology, Cardiology, Ortho). Signature required before submitting to the IRB (see page 2). Is there a Data Safety Monitoring Board? No, please explain how safety is monitored. Yes, please attach a copy of the most recent report. Has the physician(s) involved signed a Physician Financial Disclosure form? Yes No Excerpt from the IRB HUD Policy: The HUD clinical consent form should be generally modeled after other clinical consent forms for invasive procedures to include the following. It shall be the responsibility of the physician to explain risks and benefits and alternative treatment to patients more fully as set forth below in A-F. A. A description of an HDE/HUD approval process; e.g. Application for HUD Form June 2013 McLeod Health Institutional Review Board Your medical care will involve the use of (specify device), which has been approved by the U.S. Food and Drug Administration (FDA) as a Humanitarian Use Device (HUD). A HUD is a device used to diagnose or treat a disease or condition that affects fewer than 4000 individuals in the United States per year and for which no comparable device is available. The FDA approves the clinical use of a HUD based primarily on evidence that it does not pose a significant risk of injury to the patient and that the potential benefit of the device to the health of the patient outweighs the risks of its use. The FDA approval of a HUD is based on limited data documenting its effectiveness in humans. Its use does not involve research. B. A description of the HUD and how this device will be used in the clinical setting. Based on this description, it should be clear to the patient why she/he is a candidate for the use of this device. C. A discussion of possible risks, side effects, and/or adverse events associated with the HUD and its proposed clinical use. D. A discussion of the possible benefits associated with the clinical use of the HUD. E. A discussion of any alternative treatments or procedures (if any) that the patient may wish to consider in lieu of clinical application of the HUD. F. Voluntary Consent statement(s) with patient signature and date lines. Comments: Principal Physician (printed): Principal Physician Signature: _________________ ____________ _____ Date: **Administrator (VP) (printed): **Administrator (VP) Signature: Co-Principal Physician (printed): Date: ___________________ _ Co-Principal Physician Signature Date: _______ IRB USE ONLY: Primary Reviewer (printed): Primary Reviewer Signature: Date: Please send this original application along with the entire protocol and informed consent form electronically to*: Natalie S. Bee, IRB Coordinator McLeod Health - Research Department FOR IRB USE ONLY: (843) 777-2013 [email protected] Approved Deferred No action required Initial Approval IRB Approval Date: Conditional approval Disapproved Continuing Review IRB Expiration Date: *PLEASE BE SURE TO SEND ALL DOCUMENTS TO NATALIE BEE ELECTRONICALLY. 1/09, 3/11, 6/13 Application for HUD Form June 2013